AIM: The EORTC Quality of Life (QOL) Group has developed an instrument to evaluate the information received by cancer patients. This study assessed the psychometric characteristics of the EORTC INFO module in a large international/multi-cultural sample of cancer patients. METHODS: The provisional 26-item information module (EORTC INFO26) was administered with the EORTC QLQ-C30 and the information scales of the inpatient satisfaction module EORTC IN-PATSAT32 on two occasions during the patients' treatment and follow-up period. Questionnaire-hypothesised scale structure, reliability, validity and responsiveness to changes were evaluated through standard psychometric analyses. Patient acceptability was assessed with a debriefing questionnaire. RESULTS: The study comprised 509 patients from 8 countries (7 European countries and Taiwan) with different cancers and disease stages. Multi-trait scaling analysis led to the deletion of one item but confirmed the hypothesised 4 multi-item scales (information about disease, medical tests, treatment and other services) and eight single items. Internal consistency for all scales was good (α>0.70), as was test-retest reliability (intraclass correlations>0.70). All items can be combined to generate a single score (α>0.90). Convergent validity was supported by significant correlations with related areas of IN-PATSAT32 (r>0.40). Low correlations with EORTC QLQ-C30 scales confirmed divergent validity (r<0.30) The EORTC INFO-25 module discriminated among groups based on gender, age, education, levels of anxiety and depression, information wishes and satisfaction. Only one scale captured changes over time. CONCLUSIONS: The EORTC QLQ-INFO 25 is a reliable and valid self-reported instrument. The module can be used in cross-cultural observational and intervention studies.
AIM: The EORTC Quality of Life (QOL) Group has developed an instrument to evaluate the information received by cancerpatients. This study assessed the psychometric characteristics of the EORTC INFO module in a large international/multi-cultural sample of cancerpatients. METHODS: The provisional 26-item information module (EORTC INFO26) was administered with the EORTC QLQ-C30 and the information scales of the inpatient satisfaction module EORTC IN-PATSAT32 on two occasions during the patients' treatment and follow-up period. Questionnaire-hypothesised scale structure, reliability, validity and responsiveness to changes were evaluated through standard psychometric analyses. Patient acceptability was assessed with a debriefing questionnaire. RESULTS: The study comprised 509 patients from 8 countries (7 European countries and Taiwan) with different cancers and disease stages. Multi-trait scaling analysis led to the deletion of one item but confirmed the hypothesised 4 multi-item scales (information about disease, medical tests, treatment and other services) and eight single items. Internal consistency for all scales was good (α>0.70), as was test-retest reliability (intraclass correlations>0.70). All items can be combined to generate a single score (α>0.90). Convergent validity was supported by significant correlations with related areas of IN-PATSAT32 (r>0.40). Low correlations with EORTC QLQ-C30 scales confirmed divergent validity (r<0.30) The EORTC INFO-25 module discriminated among groups based on gender, age, education, levels of anxiety and depression, information wishes and satisfaction. Only one scale captured changes over time. CONCLUSIONS: The EORTC QLQ-INFO 25 is a reliable and valid self-reported instrument. The module can be used in cross-cultural observational and intervention studies.
Authors: Maria Lithner; Ulf Jakobsson; Edith Andersson; Rosemarie Klefsgård; Ingrid Palmquist; Jan Johansson Journal: J Cancer Educ Date: 2015-09 Impact factor: 2.037
Authors: Olga Husson; Melissa S Y Thong; Floortje Mols; Tineke J Smilde; Geert-Jan Creemers; Lonneke V van de Poll-Franse Journal: J Palliat Med Date: 2013-03 Impact factor: 2.947
Authors: Luca M Saadeh; Annelijn E Slaman; Eleonora Pinto; Suzanne S Gisbertz; Francesco Cavallin; Egle Jezerskyte; Rita Alfieri; Loes Noteboom; Maria Cristina Bellissimo; Matteo Cagol; Giovanni Pirozzolo; Carlo Castoro; Marco Scarpa; Mark I van Berge Henegouwen Journal: J Thorac Dis Date: 2018-08 Impact factor: 2.895
Authors: Susanne Singer; Philipp M Engelberg; Gregor Weißflog; Susanne Kuhnt; Jochen Ernst Journal: Qual Life Res Date: 2012-01-17 Impact factor: 4.147
Authors: Christiane Reinert; Katharina Rathberger; Monika Klinkhammer-Schalke; Oliver Kölbl; Martin Proescholdt; Markus J Riemenschneider; Gerhard Schuierer; Markus Hutterer; Michael Gerken; Peter Hau Journal: J Neurooncol Date: 2018-03-07 Impact factor: 4.130
Authors: Juan Ignacio Arraras; Ana Manterola; Berta Hernández; Fernando Arias de la Vega; Maite Martínez; Meritxell Vila; Clara Eito; Ruth Vera; Miguel Ángel Domínguez Journal: Clin Transl Oncol Date: 2011-06 Impact factor: 3.405
Authors: Eleonora Pinto; Francesco Cavallin; Luca Maria Saadeh; Maria Cristina Bellissimo; Rita Alfieri; Silvia Mantoan; Matteo Cagol; Carlo Castoro; Marco Scarpa Journal: Support Care Cancer Date: 2017-12-19 Impact factor: 3.603
Authors: Samer Tabchi; Elie El Rassy; Aline Khazaka; Fadi El Karak; Hampig Raphael Kourie; Ralph Chebib; Tarek Assi; Maya Ghor; Lara Naamani; Sami Richa; Marwan Ghosn; Joseph Kattan Journal: Qual Life Res Date: 2015-12-10 Impact factor: 4.147